Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

13:45 ET AbbVie Declares Quarterly Dividend

The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $1.07 per share. The cash dividend is payable August 15,...


13:00 ET German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test

Genomic Health announced today that the German Federal Joint Committee (G-BA) issued a positive reimbursement decision for the Oncotype DX Breast...


12:10 ET SPIE To Acquire Photonex, UK's Top Photonics Exhibition

SPIE, the international society for optics and photonics, has agreed to purchase Xmark Media, organizer of key UK photonics exhibitions. The...


10:29 ET Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer

Orion Biotechnology Canada Ltd., today announced new preclinical data evaluating the efficacy of OB-002 (5P12-RANTES) in colorectal cancer. BALB/c...


10:02 ET Piramal Pharma Solutions Invests $10 Million USD to Expand its High Potency API Capability in its Riverview Facility in U.S.

Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO), today announced the Grand Opening of a new wing ...


10:00 ET $26.7 Bn Biosimilars Market - Global Forecast to 2024: Increasing R&D Investment by Biopharmaceutical Companies and an Extensive Pipeline of Biosimilars

The "Biosimilars Market By Product, By Technology, By Indication, By Manufacturing Type, By Route of Administration, by Geography - Global Market...


09:45 ET N8 Medical announces Marc Rohman as new Chief Executive Officer

N8 Medical, a clinical-stage company focused on developing innovative anti-infective and anti-inflammatory solutions, today announced the appointment ...


09:19 ET New Data Shows That Karius Blood Test Can Non-Invasively Detect Pathogens In Deep Infections

Karius, a life sciences company that delivers genomic insights for infectious diseases, announced new findings that show the potential clinical...


08:35 ET NCCN and AstraZeneca Seek Opportunities to Improve Outcomes in Advanced Ovarian Cancer

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) is collaborating with AstraZeneca, a global, science-led...


08:20 ET Syntrix Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Clinical Trial of SX-682 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Melanoma

Syntrix Pharmaceuticals today announced that it has dosed the first patient in its Phase 1/2 clinical trial that will combine SX-682 with KEYTRUDA®...


08:03 ET Konica Minolta Healthcare, Novo Nordisk, Philips and Stryker join Emory Healthcare Innovation Hub with Sharecare to improve health care for all

The Emory Healthcare Innovation Hub today announced Konica Minolta Healthcare, Novo Nordisk, Philips and Stryker as its newest strategic partners...


08:00 ET Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine

Definiens, a leading international Artificial Intelligence (AI)–based biomarker analysis and advanced data mining provider for immuno-oncology...


08:00 ET Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, today announced preliminary results of a multi-center ...


08:00 ET Fujifilm at Forefront of Enterprise Imaging at SIIM 2019

(Booth #301) -- FUJIFILM Medical Systems U.S.A., Inc., leading provider of Enterprise Imaging and Medical Informatics solutions, will play a...


08:00 ET DURECT Announces $15 Million Registered Direct Offering

DURECT Corporation ("DURECT" or the "Company") (Nasdaq: DRRX) today announced that it has entered into a securities purchase agreement with certain...


08:00 ET CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business

CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that its corporate name has changed from "CollPlant...


07:50 ET 100+ Patients Treated for Erectile Dysfunction Utilizing Company's Patented CaverStem® Stem Cell Procedure with Significant Success Rate and No Adverse Effects Reported

Creative Medical Technology Holdings, Inc. (OTCQB: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and...


07:30 ET Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company, reported today that the U.S. Food and Drug Administration has...


07:00 ET CSL Behring to showcase clinical advances and insights in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with Hizentra ® [human normal immunoglobulin, 20%, subcutaneous], at the 2019 Peripheral Nerve Society Annual Meeting

Global biotherapeutics leader CSL Behring today announced that it will support the presentation of eight scientific posters at the 2019 annual...


06:49 ET Cyxone Initiates First-in-human Trial With T20K for the Treatment of MS

Cyxone (publ.), a Swedish biotech in autoimmune diseases, today announced that the company starts its first-in-human, phase I, clinical trial with...


Jun 19, 2019, 21:20 ET Akero Therapeutics Announces Pricing of Initial Public Offering

Akero Therapeutics, Inc. (NASDAQ: AKRO), a clinical-stage biotechnology company developing transformational treatments for people with non-alcoholic...


Jun 19, 2019, 21:02 ET Cryoport Announces Pricing of Public Offering of Common Stock

Cryoport, Inc. (Nasdaq: CYRX) (Nasdaq: CYRXW) ("Cryoport" or the "Company") today announced the pricing of its underwritten public offering of an...


Jun 19, 2019, 17:27 ET European Radiology portraitiert Seno Medical's bahnbrechende Brustkrebs-Diagnosetechnik

Weitere Forschungsergebnisse in der Online-Ausgabe (Open Access) von European Radiology für Juni präsentieren die bahnbrechende...


Jun 19, 2019, 17:01 ET Doctor Evidence is Empowering Researchers with an Intuitive AI Solution for Rapid Literature Review and Surveillance - Updates to a User-Friendly Interface in DOC Search

Doctor Evidence, a global health technology and consulting company in biomedical research, releases new updates and an interactive user interface for ...